Vertex Pharmaceuticals will not advance clinical trials of a treatment for Type 1 diabetes after efficacy data failed to support further clinical advancement.

The global prefilled syringes market share is projected to grow from US$ 6.69 Billion in 2022 to US$ 15.0 Billion by 2030, ...

Consumers have developed a taste for fresh brands, such as Chocolonely chocolate bars, Poppi soda, and Lesser Evil popcorn.

The "Diabetes Monitoring, Treatment and Drug Delivery Market Size, Share & Trends Analysis | United States | 2025-2031 | MedSuite | Includes: Insulin & GLP-1, Continuous Glucose Monitoring and 7 more" ...

This might surprise some, but Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) has significantly lagged the market in the ...

Introduction Biosimilar monoclonal antibodies (mAbs) are biologic drugs designed to be highly similar to already approved reference monoclonal ...

A U.S. federal judge approves a deal between Novo Nordisk (NVO) and Minnesota that settled a lawsuit over high insulin prices ...

Russian drug manufacturers are eliminating global players from the domestic insulin market, as their sales are steadily ...

Novo Nordisk leads a GLP-1 agonist market that could surpass $150 billion by 2035. Ironically, the market is passing on the ...

The bill is an extension of a pilot project passed during the 2023 legislative session that imposed a $25 cap on insulin and ...

Dr. Jitendra Singh, a renowned endocrinologist himself, emphasized the unique metabolic challenges faced by India due to its ...

By Pat Reavy, KSL.com Click here for updates on this story HIGHLAND, Utah (KSL) — Criminal charges have now been filed against a Santaquin woman accused of killing her friend to get her million dollar ...